pharma · Hepatitis C Virus Infection · Chronic Hepatitis B
Gilead Sciences Ireland
Gilead Sciences Ireland UC
Gilead Sciences is a pharma organization headquartered in Foster City, USA. Primary therapeutic focus areas include Hepatitis C Virus Infection, Chronic Hepatitis B, HIV-1-infection, HCV Infection, Crohn's Disease. NovaP
333 Lakeside Drive, Foster City, CA 94404, US HQ
1987 Founded
14,602 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- 333 Lakeside Drive, Foster City, CA 94404, US
- Founded
- 1987
- Employees
- 14,602
- Programs
- 26
- Drugs
- 17
- Patents
- 0
Sofosbuvir
Phase 3 · small molecule · Hepatitis C
Sofosbuvir for Hepatitis C is a Phase 3 program (small_molecule) at Gilead Sciences Ireland UC with 2 ClinicalTrials.gov record(s).
Internal code P7977-1231
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Gilead Sciences Ireland UC
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Hepatitis C
- Status
- completed
- Trials
- 2